John Devane

The effects of 4‐aminopyridine in multiple sclerosis patients

C. T. Bever, Douglas Young, Paul A. Anderson et al. · Neurology · 1994 · 154 citations

Medicine, Neurology, Pharmacology +15

Clinical and pharmacokinetic properties of a transdermal nicotine patch

S Mulligan, Joseph Masterson, John Devane et al. · Clinical Pharmacology & Therapeutics · 1990 · 92 citations

Public Health, Pharmacokinetics, Pharmacology +14

Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury

Keith C. Hayes, Mitchell A. Katz, John Devane et al. · The Journal of Clinical Pharmacology · 2003 · 75 citations

Medicine, Pharmacokinetics, Pharmacology +13

Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study

Y. B. Bannon, J. Corish, Owen I. Corrigan et al. · European Journal of Clinical Pharmacology · 1989 · 66 citations

Pharmacy, Pharmaceutics, Pharmacology +12

In Vivo–In Vitro Correlation (IVIVC) Modeling Incorporating a Convolution Step

Tom O’Hara, Siobhán Hayes, John D. Davis et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2001 · 58 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +10